Overview

A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects

Status:
COMPLETED
Trial end date:
2025-06-23
Target enrollment:
Participant gender:
Summary
This is a phase study to evaluate the relative bioavailability of HRS-9813 capsule and tablet in healthy subjects and the effect of food on the pharmacokinetics of HRS-9813 capsule.
Phase:
PHASE1
Details
Lead Sponsor:
Guangdong Hengrui Pharmaceutical Co., Ltd